Literature DB >> 9630092

Optimizing therapy for complex or refractory heart failure: a management algorithm.

L W Stevenson1, B M Massie, G S Francis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9630092     DOI： 10.1016/s0002-8703(98)70257-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  11 in total

Review 1.  Beta-blocker use in decompensated heart failure.

Authors:  Rami Alharethi; Ray E Hershberger
Journal:  Curr Heart Fail Rep       Date:  2006-06

2.  Heart failure: chapter 8. Treatment of end-stage heart failure.

Authors:  N de Jonge; P J M J Vantrimpont
Journal:  Neth Heart J       Date:  2004-12       Impact factor: 2.380

Review 3.  Drug Treatment of Heart Failure in Children: Gaps and Opportunities.

Authors:  Molly Weisert; Jennifer A Su; Jondavid Menteer; Robert E Shaddy; Paul F Kantor
Journal:  Paediatr Drugs       Date:  2022-01-27       Impact factor: 3.022

Review 4.  Clinical characteristics of vesnarinone.

Authors:  Arthur M Feldman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 5.  Nitroprusside in decompensated heart failure: what should a clinician really know?

Authors:  Cristina Opasich; Giovanni Cioffi; Alessandra Gualco
Journal:  Curr Heart Fail Rep       Date:  2009-09

6.  Autologous transplantation of bone marrow adult stem cells for the treatment of idiopathic dilated cardiomyopathy.

Authors:  Ricardo João Westphal; Ronaldo Rocha Loures Bueno; Paulo Bezerra de Araújo Galvão; José Zanis Neto; Juliano Mendes Souza; Ênio Eduardo Guérios; Alexandra Cristina Senegaglia; Paulo Roberto Brofman; Ricardo Pasquini; Claudio Leinig Pereira da Cunha
Journal:  Arq Bras Cardiol       Date:  2014-11-04       Impact factor: 2.000

7.  Inotropic agents use in patients hospitalized with acute decompensated heart failure: a retrospective analysis from a 22-year registry in a Middle-Eastern Country (1991-2013).

Authors:  Amer H S Aljundi; Shaban F K Mohammed; Ashfaq Patel; Rajvir Singh; Abdulrahman Arabi; Hajar A AlBinali; Jassim Al Suwaidi
Journal:  BMC Cardiovasc Disord       Date:  2016-02-19       Impact factor: 2.298

Review 8.  Is Exercise Training Appropriate for Patients With Advanced Heart Failure Receiving Continuous Inotropic Infusion? A Review.

Authors:  Eisuke Amiya; Masanobu Taya
Journal:  Clin Med Insights Cardiol       Date:  2018-01-03

9.  A clinical study of pattern and factors affecting outcome in Nigerian patients with advanced heart failure.

Authors:  O B Familoni; T O Olunuga; B W Olufemi
Journal:  Cardiovasc J Afr       Date:  2007-10-22       Impact factor: 1.167

Review 10.  Inotropes do not increase mortality in advanced heart failure.

Authors:  Maya Guglin; Marc Kaufman
Journal:  Int J Gen Med       Date:  2014-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.